ML 3000

Author：

ISSN： 1174-5886

Source： Drugs in R&D, Vol.3, Iss.3, 2002-01, pp. : 204-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery and development of ML3000

By Laufer Stefan

Inflammopharmacology, Vol. 9, Iss. 1-2, 2001-05 ,pp. : 101-112

VSP

Access to resources Recommend Favorite

ML-3000 appears to be effective in osteoarthritis

Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

The Effects of ML 3000 on Antigen-induced Responses in Sheep

By Abraham W.M. Laufer S. Tries S.

Pulmonary Pharmacology & Therapeutics, Vol. 10, Iss. 3, 1997-03 ,pp. : 167-173

Academic Press

Access to resources Recommend Favorite

The pharmacological profile of ML3000: A new pyrrolizine derivative inhibiting the enzymes cyclo-oxygenase and 5-lipoxygenase

By Tries S.

Inflammopharmacology, Vol. 9, Iss. 1-2, 2001-05 ,pp. : 113-124

VSP

Access to resources Recommend Favorite

Is the use of a 200ml vessel suitable for dissolution of low dose drug products?

By Crail D.J. Tunis A. Dansereau R.

International Journal of Pharmaceutics, Vol. 269, Iss. 1, 2004-01 ,pp. : 203-209

Elsevier

Access to resources Recommend Favorite